The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).
Ryan Dittamore
Employment or Leadership Position - Epic Sciences
Stock Ownership - Epic Sciences
Jessica Louw
Employment or Leadership Position - Epic Sciences
Stock Ownership - Epic Sciences
Rachel Krupa
Employment or Leadership Position - Epic Sciences
Stock Ownership - Epic Sciences
Aseem Anand
No relevant relationships to disclose
Daniel Costin Danila
No relevant relationships to disclose
Zaina Arslan
No relevant relationships to disclose
Natalee Bales
Employment or Leadership Position - Epic Sciences
Stock Ownership - Epic Sciences
Dena Marrinucci
Employment or Leadership Position - Epic Sciences
Stock Ownership - Epic Sciences
Howard I. Scher
Consultant or Advisory Role - Janssen; Medivation (U)
Research Funding - Medivation; Ortho Biotech; Veridex